T3 Pharmaceuticals AG’s CHF19.3 Million Series C Financing Round

Paolo Bossi Europe, Europe Legal Chronicle

VISCHER advises T3 Pharmaceuticals AG on all legal issues related to the transaction. T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here